STAND NUMBER: 5090
Ekso Bionics Europe GmbH
Ekso GT™ is the first exoskeleton cleared by the U.S. FDA and receive a CE Mark in Europe for use with stroke and spinal cord injuries from L5 to C7. The EksoGT with SmartAssist™ software is the only exoskeleton available for rehabilitation institutions that can provide adaptive amounts of power to either side of the patient`s body, challenging the patient as they progress through their continuum of care. The suit`s patented technology provides the ability to mobilize patients earlier, more frequently and with a greater number of high intensity steps. To date, this device has helped patients take more than 84 million steps in over 170 rehabilitation institutions around the world.